Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ketamine Enhancement of rTMS for Refractory Depression

To see complete record on, please visit this link

Id: NCT04352621

Organisation Name: University of Cincinnati

Overal Status: Unknown status

Start Date: May 1, 2020

Last Update: April 20, 2020

Lead Sponsor: University of Cincinnati

Brief Summary: An open label study to assess the safety, tolerability, and effects of intranasal Ketamine in combination with rTMS for patients with treatment-resistant major depressive disorder (TRD). Patients will be given a dose of ketamine followed by 6 weeks of rTMS treatment.

  • Major Depressive Disorder

Total execution time in seconds: 0.62545990943909